Growth-signaling research
Distinct analogue records for reviewing growth-signaling pathways.
Exploratory comparison · upstream/downstream overlap
Shared GH/IGF-axis signaling introduces overlap and feedback. Evidence for tesamorelin alone does not validate an LR3 combination or a muscle-development outcome.
Contrasts an upstream GHRH analogue with a downstream engineered IGF analogue. The distinction is useful for literature comparison, not evidence that increasing both levels of the same axis is complementary.
Published findings concern the stated study materials and models. They do not establish the exact catalog combination.
Individual product records, together for review.
1 vial
$65
TESA is a synthetic 44-residue analogue of human growth hormone-releasing hormone, distinguished by an N-terminal trans-3-hexenoic acid modification. It belongs to the full-length GHRH analogue family and is supplied as a sealed vial of lyophilized powder for laboratory research.
Lot documentation published
1 vial
$65
IGF-1 LR3 is an 83-residue recombinant analogue of insulin-like growth factor 1, with an arginine substitution and a 13-amino-acid N-terminal extension. It is a small-protein research material rather than a conventional short peptide and is supplied as lyophilized powder in a sealed vial.
Lot documentation published
One vial of each included product.
Individual value: $130Save $10
Ask about Muscle Development
Contact us for current availability and lot documentation for the products in this selection.
Laboratory research only. Goal labels describe research themes, not promised outcomes or combined-use guidance. Each product is a separate catalog record. Not for human or veterinary use.